Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Basic & Clinical Pharmacology & Toxicology|March 27, 2013
Sex difference in formation of propofol metabolites: a replication studyEva Choong, Irena Loryan, Marja Lindqvist, et al.
International Journal of Antimicrobial Agents|November 24, 2024
Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)Amaury O'Jeanson, Konstantinos Ioannidis, Elisabet I Nielsen, et al.
European Journal of Clinical Pharmacology|October 19, 2011
Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesiaIrena Loryan, Marja Lindqvist, Inger Johansson, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2026
Pharmacokinetic-pharmacodynamic modeling to evaluate the relative impact of immune response and meropenem on bacterial killing <i>in vivo</i>Raphaël Saporta, Natália Tassi, Veronica Biordi, et al.
Pharmaceutical Research|March 14, 2026
Evaluation of sNfL as a Biomarker for Paclitaxel-Induced Peripheral Neurotoxicity Through an Integrated PKPD ModelEman I K Ibrahim, Milda Girdenyté, Yang Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 22, 2023
Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk projectDavid Balayssac, Jérôme Busserolles, Catherine Broto, et al.
Pageof 4